It turns out that spending $609,000 a day on lobbying can be a great investment. Health reform is looking to be very, very good for the pharmaceutical business. Jon Cohn has new evidence on why we should take their complaints about the bill with two aspirin–and a grain of salt.
-
-
Full ListMost Popular
- The Foreclosure Deal: Obama and the Banks Win Big While Homeowners See Modest Reward
- Four Ways the U.S. Could End Up at War with Iran Before the Election*
- Fears, Faith and Freedom at CPAC
- Mitt Romney’s Sweet Spot: Just Conservative Enough
- Conflict Over Obama’s Contraception Rule Intensifies
- A Brief Photographic History of Glitter-Bombs
- Not Farewell, But Fare Forward
- Morning Must Reads: Accommodation
- When Can We Call Ron Paul’s Caucus Strategy a Bust?
- Rick Santorum’s Unlucky Timing
- Icelanders Avoid Inbreeding Through Online Incest Database
- The 2012 World Press Photo of the Year
- Top 10 Celebrity Restaurants
- Why American Kids Are Brats
- A Cancer Drug Reverses Alzheimer's Disease in Mice
- Jimmy Stewart: A Hero Home From the War
- The Second Coming of Warren Jeffs: The Jailed Polygamist Leader Prepares His Flock for Doomsday
- Why Is Your Boss Moving to Brazil?
- The Foreclosure Deal: Obama and the Banks Win Big While Homeowners See Modest Reward
- Oscars 2012: Great Performances
-
-
VideoMore Videos
-





